Jumpcode Genomics Raises $21M in Series B Funding

– Jumpcode Genomics is a San Diego, CA-based genome technology company focused on improving the understanding of human disease.
– The company raised $21m in Series B funding.
– The round was co-led by Baird Capital and Arboretum Ventures with participation from existing investor LYZZ Capital.
– In conjunction with the funding, Frank Witney joined Jumpcode’s Board of Directors.